Decision aids and prostate cancer: how useful are they?

Your sitemaster has long had concerns about the real value of decision aids in helping men to think about and come to conclusions about controversial issues in the diagnosis and management of prostate cancer. … READ MORE …

Patient satisfaction at 24 months after treatment for localized prostate cancer

The ability to “manage” patients’ satisfaction with their care in the treatment of localized prostate cancer is challenging — for patients, for caregivers, for physicians, and for health systems. … READ MORE …

Decision aids and decision-making in prostate cancer risk

Your sitemaster has long believed that, while electronic and other decision aids can be helpful in providing men with information and education about prostate cancer, their value in helping them to make the best decisions is less clear. … READ MORE …

Don’t underestimate George Berger!

Don’t underestimate patients” is a new blog post on The Health Care Blog web site by George Berger, who is a regular commentator on the posts on this web site. … READ MORE …

The value of second opinions, and who one gets them from

An interesting new paper published this morning in Cancer has shown that while lots of men have been getting second opinions from urologists on what to do about a diagnosis of prostate cancer, those second opinions don’t seem to have had much impact on their care. … READ MORE …

Estimation of life expectancy for newly diagnosed men with prostate cancer

A critical question for every patient newly diagnosed with prostate cancer is going to be, “How long am I going to live”? That question may be particularly important if a second and associated question is, “How long am I going to live if I just monitor my cancer on active surveillance or watchful waiting?” … READ MORE …

A highly qualified “thank you” to Drs. Welch and Albertsen — maybe?

The prostate cancer patient community should be aware of an “op-ed” in today’s New York Times by Drs. Gilbert Welch and Peter Albertsen arguing that Medicare should continue to let individual physicians make their own decisions about the use of the PSA test for risk of prostate cancer. … READ MORE …

Decision aids, PSA-based screening, and male decision-making

According to a newly published study in JAMA Internal Medicine, web-based and print-based decision aids do help men to resolve their own internal conflicts about whether or not to get PSA tests for risk of prostate cancer … READ MORE …

Management of elderly men with low- and very low-risk prostate cancer

In a newly published article in the American Journal of Clinical Oncology, Mishra et al. have attempted to assess the application of immediate, first-line treatment among older men with favorable-risk prostate cancer. … READ MORE …

Decision aids and patient choice of therapy: a randomized, controlled, clinical trial

A new paper in BJU International reports data about the development of an appropriate decision aid and the results of a randomized, controlled, clinical trial designed to investigate the effects of use of that decision aid (as opposed to “usual care”) on patients’ selection of radiation therapy as opposed to radical prostatectomy for localized disease. … READ MORE …

Another, separate look at the value of mass, PSA-based screening

For those who are really “into” the probabilistic statistics of prostate cancer decision analysis, we recommend a recent article in the journal  Medical Decision-Making. … READ MORE …

What DID the doctor actually tell you about your prostate cancer?

It is well understood that there can be big differences between what we are told and what we later say and think that we heard. It is also the case that what we are told may commonly reflect the beliefs of the person doing the telling (as opposed to actual, factual information). … READ MORE …

The CaP Calculator: a new, sophisticated, decision-support tool

Long, long ago (in September 2008), we initially reported on the existence of a prostate cancer decision support tool (then in very early-stage development) known as the CaP Calculator. … READ MORE …

The CaP Calculator — not available for patients!?

So a somewhat misinterpretable media release from ASTRO yesterday announced the development of a new tool (called the CaP Calculator) designed to help physicians advise their patients about treatment selection following a diagnosis of prostate cancer. … READ MORE …